Dansylated analogues of the opioid peptide [Dmt1]DALDA: In vitro activity profiles and fluorescence parameters

Acta Biochimica Polonica

Volumn 51, Issue 1, 2004, Pages 107-113

  Berezowska, Irena ^a   Lemieux, Carole ^a   Chung, Nga N ^a   Zelent, Bogumil ^b   Schiller, Peter W ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fluorescence quantum yield; Fluorescence spectroscopy; Fluorescent opioid peptide analogues; Opioid activity profile in vitro; Opioid peptides; Dmt1 DALDA

Indexed keywords

TYROSYL DEXTRO ARGINYLPHENYLALANYLLYSINAMIDE;

AGONIST; AMINO ACID SUBSTITUTION; ANIMAL TISSUE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BINDING; DRUG POTENCY; DRUG SELECTIVITY; DRUG UPTAKE; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; MOLECULAR INTERACTION; NONHUMAN; QUANTUM YIELD; RECEPTOR SENSITIVITY; SUBSTITUTION REACTION; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 2342527684     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2004_3601     Document Type: Conference Paper

References (13)

1. 1]DALDA. Peptides.; 24: 1195-200.
2. Chen RF. (1967) Fluorescence of dansyl amino acids in organic solvents and protein solutions. Arch Biochem Biophys.; 120: 609-20.
3. 50) of an enzymatic reaction. Biochem Pharmacol.; 22: 3099-102.
4. DiMaio J, Nguyen TM-D, Lemieux C, Schiller PW. (1982) Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogues: effects of conformational constraints on opiate receptor selectivity. J Med Chem.; 25: 1432-8.
5. Parker CW, Godt SM, Johnson MC. (1967) Fluorescent probes for the study of the antibody-hapten reaction. II. Binding of the 5-dimethylaminonaphthalene- 1-sulfonamido group by homologous rabbit antibody. Biochemistry.; 6: 3408-16.
6. 21-ACTH-(1-24)-tetrakosipeptide. Proc Natl Acad Sci U S A.; 69: 975-9.
7. Schiller PW, Lipton A, Horrobin DF, Bodanszky M. (1978) Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor. Biochem Biophys Res Commun.; 85: 1332-8.
8. Schiller PW, Nguyen TM-D, Chung NN, Lemieux C. (1989) Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high μ-opioid receptor selectivity. J Med Chem.; 32: 698-703.
9. Schiller PW, Nguyen TM-D, Berezowska I, Dupuis S, Weltrowska G, Chung NN, Lemieux C. (2000) Synthesis and in vitro opioid activity profiles of DALDA analogues. Eur J Med Chem.; 35: 895-901.
10. 21- adrenocorticotropin-(1-24)-tetrakosipeptid. Helv Chim Acta.; 54: 897-904.
11. 65-analogue. Comparison of the binding properties of methionine- and leucine-enkephalin. Eur J Pharmacol.; 58: 11-8.
12. Zhao G-M, Wu D, Soon Y, Shimoyama M, Berezowska I, Schiller PW, Szeto HH. (2002) Profound spinal tolerance after repeated exposure to a highly selective μ-opioid peptide agonist: role of δ-opioid receptors. J Pharmacol Exp Ther.; 302: 188-96.
13. Zhao K, Luo G, Zhao G-M, Schiller PW, Szeto HH. (2003) Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. J Pharmacol Exp Ther.; 304: 425-32.